The Enterprise Value as of December 2025 (TTM) for Jiangsu Recbio Technology Co., Ltd. (2179.HK) is 2.93B

According to Jiangsu Recbio Technology Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 2.93B. This represents a change of -32.08% compared to the average of 4.31B of the last 4 quarters.

Jiangsu Recbio Technology Co., Ltd. (2179.HK) Historical Enterprise Value (quarterly & annually)

How has 2179.HK Enterprise Value performed in the past?

The mean historical Enterprise Value of Jiangsu Recbio Technology Co., Ltd. over the last ten years is 7.85B. The current 2.93B Enterprise Value has changed 3.62% with respect to the historical average. Over the past ten years (40 quarters), 2179.HK's Enterprise Value was at its highest in in the December 2020 quarter at 9.85B. The Enterprise Value was at its lowest in in the June 2020 quarter at 0.

Jiangsu Recbio Technology Co., Ltd. (2179.HK) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Jiangsu Recbio Technology Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Jiangsu Recbio Technology Co., Ltd. (2179.HK) Average Enterprise Value

How has 2179.HK Enterprise Value performed in the past?

The current Enterprise Value of Jiangsu Recbio Technology Co., Ltd. (2179.HK) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Jiangsu Recbio Technology Co., Ltd. (2179.HK) Enterprise Value vs. Peers

How is 2179.HK’s Enterprise Value compared to its peers?

Jiangsu Recbio Technology Co., Ltd.’s Enterprise Value is greater than Clover Biopharmaceuticals, Ltd. (2.59B), greater than ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (1.97B), greater than Antengene Corporation Limited (1.68B), greater than Cutia Therapeutics (1.58B), greater than HighTide Therapeutics Inc (1.24B), less than AIM Vaccine Co., Ltd. (5.30B), greater than Hua Medicine (Shanghai) Ltd. (2.03B), greater than Zhaoke Ophthalmology Limited (712.75M), greater than SinoMab BioScience Limited (1.92B), greater than Mabpharm Limited (2.19B),

Build a custom stock screener for Jiangsu Recbio Technology Co., Ltd. (2179.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Jiangsu Recbio Technology Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Jiangsu Recbio Technology Co., Ltd. (2179.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Jiangsu Recbio Technology Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.